The Frida Blog

Plain-language, educational articles on schizophrenia, psychosis, antipsychotic medications, and lived experience — by ColdAI.

979 articles, updated weekly

Browse by topic

Schizophrenia Overview(130) Psychosis & Episodes(81) Medications(150) Side Effects(34) Famous People with Schizophrenia(35) Patient Experiences(120) CBT for Psychosis(66) Hospitalisation & Crisis(53) Lifestyle & Wellbeing(242) For Families & Caregivers(50) Engineering(17) Schizophrenia Research(1)

Latest articles

IEPs and 504 plans for students with schizophrenia

An IEP and a 504 plan are different legal tools that help students with disabilities. Here's how to choose between them when schizophrenia is in the picture.

Myth: Antipsychotics turn people into zombies

The 'medication zombie' image comes from old, high-dose typical antipsychotics. Modern prescribing aims for the lowest effective dose — and most people on it do not feel flat.

Indigenous communities and schizophrenia care

Indigenous communities in the US carry a disproportionate burden of trauma, suicide, and serious mental illness — and the federal system meant to provide their care has been chronically underfunded for generations.

Swelling and edema from antipsychotics: what is going on

Peripheral edema — swelling of the lower legs and feet — is an uncommon but recognised antipsychotic side effect. Here is the differential and what to do about it.

Olfactory hallucinations: phantom smells

Smelling something that nobody else can smell is unsettling. In most cases the cause is neurological or ENT-related, but olfactory hallucinations can also occur in schizophrenia.

Going back to work after the psychiatric hospital

Three weeks in a psychiatric hospital can change a lot, including the question of whether you can do your job. A composite story of going back.

Caring for a sibling with schizophrenia when you're the only one left

When you're the last person standing for a sibling with schizophrenia, the responsibility is uniquely heavy. This guide covers the practical and emotional work.

Family therapy and family psychoeducation for schizophrenia

Family psychoeducation is one of the few interventions in psychiatry that consistently reduces relapses. It is also one of the least available. Here's why it matters.

Self-employment with schizophrenia: freelancing and small business

Self-employment can be a great fit for people with schizophrenia — flexible hours, controlled environment, no boss. It also strips away structure and benefits. Here is how to weigh it.

WRAP (Wellness Recovery Action Plan) for schizophrenia

WRAP — the Wellness Recovery Action Plan — is a self-management framework developed by Mary Ellen Copeland and used by hundreds of thousands of people in mental health recovery worldwide.

Art therapy for schizophrenia: what NICE recommends and why

Art therapy is specifically recommended in UK NICE guidelines for schizophrenia, particularly for negative symptoms. Here is what the practice looks like and what the evidence actually says.

Trauma-informed care in psychosis: why it matters and what it changes

Trauma is far more common in people with schizophrenia than in the general population — and standard psychiatric care can sometimes retraumatise. Trauma-informed care is the alternative.

CBTp vs medication: the wrong question, with a useful answer

Asking whether CBT can replace antipsychotics frames the problem badly. The real question is which combination, in what sequence, for which person.

Neuroleptic malignant syndrome (NMS): a medical emergency

Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal reaction to antipsychotic medication. Recognising the warning signs early can save a life.

Uzedy (risperidone subcutaneous LAI): once-monthly or every 2 months

Uzedy is a newer subcutaneous risperidone LAI that offers once-monthly or every-two-month dosing, no loading dose, and no required oral overlap. Here's how it compares.

Pimozide: the antipsychotic for delusional disorder

Pimozide has a narrow but distinctive role: FDA-approved for Tourette syndrome, long associated off-label with delusional disorder, and demanding careful cardiac monitoring.

Paliperidone side effects: prolactin, EPS, what to watch for

Paliperidone shares much of risperidone's profile — including prolactin elevation and movement effects — but has its own dosing logic that shapes the experience.

Cariprazine (Vraylar): the D3-preferring partial agonist

Cariprazine is a partial dopamine agonist that prefers the D3 receptor, with growing evidence in negative symptoms of schizophrenia and bipolar depression.

Virginia Woolf: the unsettled diagnostic debate

Virginia Woolf had several severe mental health episodes across her life and died by suicide in 1941. The exact diagnosis remains contested — but the record itself is rich and worth careful reading.

Ross David Burke: the posthumous memoir 'When the Music's Over'

Ross David Burke spent the last years of his life writing a detailed account of his own schizophrenia. The book, edited by his clinicians and published after his death, remains one of the most candid first-person records of the illness.

Eduard Einstein: Albert Einstein's son and a life inside an asylum

Eduard Einstein, the younger son of Albert and Mileva, was diagnosed with schizophrenia at twenty. He spent most of the rest of his life in the Burghölzli psychiatric hospital in Zurich, separated from his father by an ocean and by a treatment philosophy of the era.

Schizoaffective disorder: when psychosis and mood disorder overlap

Schizoaffective disorder sits in the territory between schizophrenia and bipolar or depressive illness. The diagnosis is precise — and the treatment approach reflects both halves.

Mismatch negativity (MMN): a candidate biomarker for schizophrenia

Mismatch negativity is one of the most reliable biological abnormalities ever found in schizophrenia — and a window into NMDA receptor function in the living brain.

Coordinated Specialty Care (CSC): the team-based model for first-episode psychosis

Coordinated Specialty Care brings a multidisciplinary team around young people in their first episode of psychosis. It is now the standard of care in much of the US.

The SCID interview: what to expect

The SCID-5 is the structured interview used in research and difficult clinical cases to confirm a DSM-5 diagnosis. Here is what it looks like and how to prepare.

Schizophrenia vs schizoaffective disorder: what's the difference?

Schizoaffective disorder sits at the intersection of schizophrenia and a mood disorder (depression or bipolar). The diagnostic difference matters for treatment.

Metabolic syndrome from antipsychotics

Metabolic syndrome is the cluster of risk factors — abdominal weight, glucose, lipids, blood pressure — that drives cardiovascular disease. Antipsychotics push every one of them in the wrong direction.

Buddhist perspectives on living with schizophrenia

Buddhist teachings on impermanence, compassion, and the nature of mind can offer real support to people living with schizophrenia — alongside, not instead of, medical care.

Schneider's first-rank symptoms: history and modern relevance

Kurt Schneider's first-rank symptoms once defined schizophrenia almost on their own. Modern diagnostic systems have stepped back from that idea — but the symptoms themselves still matter.

EMDR for trauma in psychosis: what the research shows

Eye Movement Desensitisation and Reprocessing has moved from the margins of trauma care to the mainstream. For people with psychosis and PTSD, the evidence now supports its use.